StockData

Escalon Medical Corp (ESMC) stock

ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026Score 10/30
$0.18+0.01 (+7.65%)

Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –

Escalon Medical gross margin

Gross margin is gross profit as a percentage of revenue.

Escalon Medical's gross margin for the twelve months ending Jun 30, 2026 was 43.7%. For fiscal 2026 it was 43.7%, against 45.7% the year before. The highest annual figure on record is 49.7% in fiscal 2012.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202643.7%−2.0
FY2025Jun 30, 202545.7%+2.8
FY2024Jun 30, 202443.0%−2.1
FY2023Jun 30, 202345.0%+2.0
FY2022Jun 30, 202243.0%+0.8
FY2021Jun 30, 202142.3%−2.4
FY2020Jun 30, 202044.7%−3.4
FY2019Jun 30, 201948.1%+3.3
FY2018Jun 30, 201844.8%−1.1
FY2017Jun 30, 201745.9%−0.6
FY2016Jun 30, 201646.5%−0.2
FY2015Jun 30, 201546.7%−2.4
FY2014Jun 30, 201449.1%+0.4
FY2013Jun 30, 201348.6%−1.1
FY2012Jun 30, 201249.7%+17.2
FY2011Jun 30, 201132.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2026CQ2 2026Jun 30, 202650.4%+6.7
Q3 FY2026CQ1 2026Mar 31, 202636.3%−9.8
Q2 FY2026CQ4 2025Dec 31, 202543.3%−5.5
Q1 FY2026CQ3 2025Sep 30, 202541.9%−1.7
Q4 FY2025CQ2 2025Jun 30, 202543.7%+1.3
Q3 FY2025CQ1 2025Mar 31, 202546.1%+4.6
Q2 FY2025CQ4 2024Dec 31, 202448.9%+4.9
Q1 FY2025CQ3 2024Sep 30, 202443.6%−0.4
Q4 FY2024CQ2 2024Jun 30, 202442.4%−4.1
Q3 FY2024CQ1 2024Mar 31, 202441.4%−8.5
Q2 FY2024CQ4 2023Dec 31, 202344.0%+2.3
Q1 FY2024CQ3 2023Sep 30, 202344.0%+3.5
Q4 FY2023CQ2 2023Jun 30, 202346.5%−4.9
Q3 FY2023CQ1 2023Mar 31, 202349.9%+11.1
Q2 FY2023CQ4 2022Dec 31, 202241.7%−1.3
Q1 FY2023CQ3 2022Sep 30, 202240.6%+2.8
Q4 FY2022CQ2 2022Jun 30, 202251.4%+4.0
Q3 FY2022CQ1 2022Mar 31, 202238.8%−1.7
Q2 FY2022CQ4 2021Dec 31, 202143.0%+0.5
Q1 FY2022CQ3 2021Sep 30, 202137.8%+0.1
Q4 FY2021CQ2 2021Jun 30, 202147.4%+11.3
Q3 FY2021CQ1 2021Mar 31, 202140.5%−5.2
Q2 FY2021CQ4 2020Dec 31, 202042.5%−4.5
Q1 FY2021CQ3 2020Sep 30, 202037.7%−10.9
Q4 FY2020CQ2 2020Jun 30, 202036.1%−15.0
Q3 FY2020CQ1 2020Mar 31, 202045.7%−2.0
Q2 FY2020CQ4 2019Dec 31, 201947.0%−0.1
Q1 FY2020CQ3 2019Sep 30, 201948.6%+1.8
Q4 FY2019CQ2 2019Jun 30, 201951.0%+5.8
Q3 FY2019CQ1 2019Mar 31, 201947.6%+4.1
Q2 FY2019CQ4 2018Dec 31, 201847.1%+1.4
Q1 FY2019CQ3 2018Sep 30, 201846.7%+2.5
Q4 FY2018CQ2 2018Jun 30, 201845.3%−0.4
Q3 FY2018CQ1 2018Mar 31, 201843.6%−2.2
Q2 FY2018CQ4 2017Dec 31, 201745.7%−0.2
Q1 FY2018CQ3 2017Sep 30, 201744.2%−2.1
Q4 FY2017CQ2 2017Jun 30, 201745.6%–
Q3 FY2017CQ1 2017Mar 31, 201745.8%–
Q2 FY2017CQ4 2016Dec 31, 201645.9%–
Q1 FY2017CQ3 2016Sep 30, 201646.3%–

More Escalon Medical figures

See a number that looks wrong?